Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yiaikang capsule for prevention of pulmonary infections in AIDS patients receiving HAART
ChiCTR1800018255Phase 2Not yet recruiting
- Sponsor
- First Affiliated Hospital of Henan University of Chinese Medicine
- Start
- Oct 2018
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of yiaikang in human immunodeficiency virus infection (HIV) and acquired immunodeficiency syndrome (AIDS) (2 arms), sponsored by First Affiliated Hospital of Henan University of Chinese Medicine. Primary endpoint: Incidence of pulmonary infectious diseases. Planned start Oct 2018; status: not yet recruiting.
02
Drugs
yiaikang
03
Conditions
human immunodeficiency virus infection (HIV)acquired immunodeficiency syndrome (AIDS)
Beyond the preview
Go deeper on ChiCTR1800018255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018255.